Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Pakistan

Pakistan Articles

Industry

BMI View: The Solomon Islands will continue to rely on aid to improve healthcare access. The country has a high burden of non-communicable and communicable diseases, which makes efficient... 2012-07-06


Industry

BMI View: Despite the significant presence of multinationals in Pakistan and the country's market potential, the leading international firms' local activity remains minimal, largely... 2011-08-19


Industry

BMI View: While Pakistan boasts a substantial population of 174mn people, annual per-capita expenditure on pharmaceuticals is very modest at just US$10. Despite expected economic progress,... 2011-06-30


More ARTICLES

Industry

BMI view: There are significant hurdles on GlaxoSmithKline Pakistan's road towards fully exploiting Pakistan's untapped potential, not least the country's weak distribution infrastructure,... 2011-05-18


Economy

Developed state underperformance remains a recurring theme within our Industry analysis. We remain concerned about US labour market weakness and its impact, particularly on consumer... 2010-09-28


Industry

GlaxoSmithKline Pakistan's financial performance has been impaired by a challenging business environment, according to the company's senior executive. In an interview with Bloomberg,... 2010-07-09


Industry

BMI believes the strategy adopted by Searle Pakistan is advisable given the challenging operating environment in the South Asian country. The Karachi-based drugmaker dramatically... 2010-04-21


Industry

Combined sales of prescription drugs and over-the-counter (OTC) medicines in Pakistan are forecast to increase from PKR132bn (US$1.62bn) in 2009 to PKR144bn (US$1.64bn) in 2010. Due... 2010-04-20